Besides, antitumour activities of CED in lung cancer rely on the inhibitory activity against the VEGFR family and the platelet-derived growth factor receptor- (PDGFR-) related kinases c-Kit, PDGFR-α, and PDGFR-β [21]. This evidence concerns the gene KDR and lung cancer.